home / stock / amti / amti news

AMTI News and Press, Applied Molecular Transport Inc. From 03/29/22

Stock Information
Company Name: Applied Molecular Transport Inc.
Stock Symbol: AMTI
Market: NASDAQ
Website: appliedmt.com
Menu
AMTI AMTI Quote AMTI Short AMTI News AMTI Articles AMTI Message Board
Get AMTI Alerts

News, Short Squeeze, Breakout and More Instantly...
AMTI - SPRO,AMTI and BRZE among after hour movers

Gainers: Qurate Retail (QRTEA) +19%. lululemon athletica  (LULU) +7%. Cue Health  (HLTH) +7%. Spero Therapeutics (SPRO) +6%. Applied Molecular Transport  (AMTI) +6%. Losers: Stronghold Digital Mining (SDIG) -26%. Braze (BRZE) -11%. Global-E Online ...
AMTI - Applied Molecular Transport Appoints Industry Veteran Carolyn Finkle as Senior Vice President, Head of Regulatory Affairs

Company continues to strengthen key functions and corporate leadership Company on track to announce top-line data from four ongoing oral AMT-101 Phase 2 trials in 2022 SOUTH SAN FRANCISCO, Calif., March 14, 2022 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: A...

AMTI - How Russia's invasion of Ukraine may impact pharma-biotech R&D

As the Russian invasion of Ukraine continues, several pharma and biotech companies have exposure to both countries through clinical trials being conducted there. One biotech, Karuna Therapeutics (NASDAQ:KRTX), has already said the disturbance has impacted a late-stage trial. On Thursday, the ...

AMTI - Applied Molecular Transport GAAP EPS of -$0.78 misses by $0.12

Applied Molecular Transport press release (NASDAQ:AMTI): Q4 GAAP EPS of -$0.78 misses by $0.12. “We are looking forward to a catalyst-rich year in 2022 for AMT,” said Tahir Mahmood, Ph.D., chief executive officer and co-founder of AMT. “The Company is well-prepared a...
AMTI - Applied Molecular Transport Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Four top-line data readouts expected in 2022 from ongoing oral AMT-101 Phase 2 trials, as follows FILLMORE monotherapy trial for patients with chronic pouchitis followed by MARKET combination trial with anti-TNF α in ulcerative colitis (UC) in H1 2022 LO...

AMTI - Applied Molecular Transport to Present at SVB Leerink Virtual 11th Annual Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the...

AMTI - Applied Molecular Transport Announces Board Appointments

John W. Smither Appointed to its Board of Directors and Named Audit Committee Chair Graham K. Cooper Named Executive Chair Helen S. Kim Named Lead Independent Director SOUTH SAN FRANCISCO, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Applied Molecular Tran...
AMTI - PROC, JWEL and CPE among technology movers

Gainers: iSpecimen  ISPC +117%. Biofrontera  BFRI +75%. Allied Healthcare Products AHPI +64%. NRx Pharmaceuticals NRXP +57%. Adagio Therapeutics ADGI +30%. Losers: Procaps Group (NASDAQ:PROC) -18%. Jowell Global Ltd (NASDAQ:JWEL) -17%. Pinduoduo PD...

AMTI - CPE, SABR and LPI among mid-day movers

Gainers: iSpecimen (NASDAQ:ISPC) +115%. Biofrontera (NASDAQ:BFRI) +68%. Allied Healthcare Products (NASDAQ:AHPI) +56%. NRx Pharmaceuticals (NASDAQ:NRXP) +52%. Adagio (NASDAQ:ADGI) +31%. Alpha Pro Tech (NYSE:APT) +23%. 180 Life Sciences (NASDAQ:ATNF) +20%. Moderna (NASDAQ:MRNA) +22%. SAB Bioth...

AMTI - Applied Molecular Transport to Present at Virtual Jefferies London Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Bittoo Kanwar, M.D., chief medical officer, and Liz Bhatt, chief business and strategy officer, will partici...
Previous 10 Next 10